Streptococcus pneumoniae serotype 19A: worldwide epidemiology

R Isturiz, HL Sings, B Hilton, A Arguedas… - Expert review of …, 2017 - Taylor & Francis
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …

The relationship between pneumococcal serotypes and antibiotic resistance

JH Song, R Dagan, KP Klugman, B Fritzell - Vaccine, 2012 - Elsevier
Streptococcus pneumoniae (SP) causes significant burden of disease, including invasive
pneumococcal disease and noninvasive diseases such as pneumonia and acute otitis …

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

L Simonsen, RJ Taylor, C Schuck-Paim… - The Lancet …, 2014 - thelancet.com
Summary Background In March 2010, 13-valent pneumococcal conjugate vaccine (PCV13)
replaced the seven-valent vaccine in the USA. We assessed the effect of PCV13 use on …

[HTML][HTML] Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology

MA Fletcher, HJ Schmitt, M Syrochkina… - European journal of …, 2014 - Springer
This review evaluates the serotype epidemiology of complicated pneumococcal pneumonia
(CPP) during the period 1990–2012. PubMed and EMBASE were searched using the terms …

Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997–2010 in Utah

C Stockmann, K Ampofo, CL Byington, F Filloux… - …, 2013 - publications.aap.org
BACKGROUND: After licensure of the 7-valent pneumococcal conjugate vaccine (PCV7) in
the United States in 2000, the incidence of pediatric pneumococcal meningitis decreased …

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal …

RE Mendes, AJ Costello, MR Jacobs, D Biek… - … and infectious disease, 2014 - Elsevier
This study evaluated pneumococci cultured from blood or lower respiratory tract specimens
from hospitalized patients in the USA (all age groups) during 2011–2012 (N= 1190) and …

Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine

PYI Tam, LC Madoff, B Coombes, SI Pelton - Pediatrics, 2014 - publications.aap.org
OBJECTIVE: To examine whether there is a different clinical profile and severity of invasive
pneumococcal disease (IPD) in children caused by nonvaccine types in the era of 13-valent …

Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae

S Nakano, Y Matsumura, Y Ito, T Fujisawa… - European Journal of …, 2015 - Springer
Surveillance of Streptococcus pneumoniae serotypes is important for the successful
implementation of vaccination strategies to prevent the spread of invasive pneumococcal …

[HTML][HTML] Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a …

IF Gutiérrez-Tobar, JP Londoño-Ruiz, C Mariño-Drews… - Vaccine, 2022 - Elsevier
Abstract Background Pneumococcal conjugate vaccines (PCVs) have decreased
pneumonia in children. Colombia introduced mass vaccination with PCV10 in 2012 …

Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England

S Saxena, C Atchison, E Cecil, M Sharland, E Koshy… - Journal of Infection, 2015 - Elsevier
Objectives A wider spectrum 13-valent pneumococcal vaccine (PCV13) replaced PCV7 in
the child immunization schedule in England from 2010. We assessed the additional impact …